Press Releases

Other News

Aug 20 2024

Intervju med Øystein Rekdal i Finansavisen Børsmorgen:

Aug 16 2024

View Lytix Biopharma's presentation of Phase II clinical results in Basal Cell Carcinoma

Apr 22 2024

CEO Presentation and Q&A with Redeye AB

Nov 27 2023

Øystein Rekdal, CEO in Lytix Biopharma, presented at Redeye Life Science Day 2023 in Stockholm – 23rd of November

Aug 18 2023

Redeye interviewed Øystein Rekdal about Lytix and his role as CEO